Literature DB >> 34919346

Opioid use among Medicare beneficiaries with knee osteoarthritis: prevalence and correlates of chronic use.

Elena Losina1,2,3, Shuang Song1, Gordon P Bensen1, Jeffrey N Katz1,2,4.   

Abstract

OBJECTIVE: To determine the prevalence of chronic and occasional opioid use and identify risk factors of opioid use among persons with knee osteoarthritis.
METHODS: We used the Medicare Current Beneficiary Survey (MCBS) to select a knee OA cohort. We obtained data on demographics, marital status, comorbidities, insurance and prescription medication coverage from survey data and linked Medicare claims. We included all prescribed medication records classified as opioid under the First Databank therapeutic antiarthritics or analgesics categories. We stratified knee OA subjects into three opioid use groups: 1) non-users (0 prescriptions/year), 2) occasional users (1-5 prescriptions/year) and 3) chronic users (6+ prescriptions/year). We built multivariable logistic regression models using a Generalized Estimating Equation (GEE) to determine correlates of chronic opioid use.
RESULTS: Among 3,549 Medicare beneficiaries with knee OA and a mean age of 78 (SD 7) years, 68% were females, 9% were chronic users and 21% used opioids occasionally. Multivariable analysis showed that non-Hispanic ethnicity (OR 4.8, 95% CI [2.2, 10.2]), divorced status (vs. married) (OR 2.3, 95% CI [1.5, 3.5]), Medicaid eligibility (OR 1.9, 95% CI [1.3, 2.7]), depression (OR 1.9, 95% CI [1.5, 2.5]), COPD (OR 1.9, 95% CI [1.4, 2.5]) and inability to walk without assistive devices (vs. no difficulty walking) (OR 2.4, 95% CI [1.5, 3.7]) were independently associated with chronic opioid use.
CONCLUSION: 9% of persons with knee OA use opioids chronically. Efforts to find non-opioid regimens for treating knee OA pain should be tailored to patients at high risk for chronic use. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2021        PMID: 34919346      PMCID: PMC9203600          DOI: 10.1002/acr.24844

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   5.178


  31 in total

1.  Impact of Preoperative Opioid Use on Total Knee Arthroplasty Outcomes.

Authors:  Savannah R Smith; Jennifer Bido; Jamie E Collins; Heidi Yang; Jeffrey N Katz; Elena Losina
Journal:  J Bone Joint Surg Am       Date:  2017-05-17       Impact factor: 5.284

2.  Pain sensitivity in former opioid addicts.

Authors:  P M Liebman; M Lehofer; M Schönauer-Cejpek; T Legl; G Pernhaupt; M Moser; K Schauenstein
Journal:  Lancet       Date:  1994-10-08       Impact factor: 79.321

3.  Trends in prescription of opioids from 2003-2009 in persons with knee osteoarthritis.

Authors:  Elizabeth A Wright; Jeffrey N Katz; Stanley Abrams; Daniel H Solomon; Elena Losina
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-10       Impact factor: 4.794

4.  Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-11-04       Impact factor: 17.586

5.  Are We Still Prescribing Opioids for Osteoarthritis?

Authors:  David E DeMik; Nicholas A Bedard; S Blake Dowdle; Robert A Burnett; Michael A McHugh; John J Callaghan
Journal:  J Arthroplasty       Date:  2017-07-25       Impact factor: 4.757

6.  Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.

Authors:  J N Katz; S R Smith; J E Collins; D H Solomon; J M Jordan; D J Hunter; L G Suter; E Yelin; A D Paltiel; E Losina
Journal:  Osteoarthritis Cartilage       Date:  2015-10-23       Impact factor: 6.576

7.  Cost-Effectiveness of Tramadol and Oxycodone in the Treatment of Knee Osteoarthritis.

Authors:  Savannah R Smith; Jeffrey N Katz; Jamie E Collins; Daniel H Solomon; Joanne M Jordan; Lisa G Suter; Edward H Yelin; A David Paltiel; Elena Losina
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-12-31       Impact factor: 4.794

Review 8.  2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.

Authors:  Sharon L Kolasinski; Tuhina Neogi; Marc C Hochberg; Carol Oatis; Gordon Guyatt; Joel Block; Leigh Callahan; Cindy Copenhaver; Carole Dodge; David Felson; Kathleen Gellar; William F Harvey; Gillian Hawker; Edward Herzig; C Kent Kwoh; Amanda E Nelson; Jonathan Samuels; Carla Scanzello; Daniel White; Barton Wise; Roy D Altman; Dana DiRenzo; Joann Fontanarosa; Gina Giradi; Mariko Ishimori; Devyani Misra; Amit Aakash Shah; Anna K Shmagel; Louise M Thoma; Marat Turgunbaev; Amy S Turner; James Reston
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-01-06       Impact factor: 4.794

9.  Opioid Prescription Patterns and Risk Factors Associated With Opioid Use in the Netherlands.

Authors:  Ajda Bedene; Willem M Lijfering; Marieke Niesters; Monique van Velzen; Frits R Rosendaal; Marcel L Bouvy; Albert Dahan; Eveline L A van Dorp
Journal:  JAMA Netw Open       Date:  2019-08-02

10.  Factors related to the use of opioids as early treatment in patients with knee osteoarthritis.

Authors:  Soo-Kyung Cho; Sun-Young Jung; Seongmi Choi; Seul Gi Im; Hyoungyoung Kim; Woo Seok Choi; Eun Jin Jang; Yoon-Kyoung Sung
Journal:  Arthritis Res Ther       Date:  2019-11-04       Impact factor: 5.156

View more
  2 in total

1.  Patient characteristics, pain treatment patterns, and incidence of total joint replacement in a US population with osteoarthritis.

Authors:  Mayura Shinde; Carla Rodriguez-Watson; Tancy C Zhang; David S Carrell; Aaron B Mendelsohn; Young Hee Nam; Amanda Carruth; Kenneth R Petronis; Cheryl N McMahill-Walraven; Aziza Jamal-Allial; Vinit Nair; Pamala A Pawloski; Anne Hickman; Mark T Brown; Jennie Francis; Ken Hornbuckle; Jeffrey S Brown; Jingping Mo
Journal:  BMC Musculoskelet Disord       Date:  2022-09-23       Impact factor: 2.562

2.  Societal Cost of Opioid Use in Symptomatic Knee Osteoarthritis Patients in the United States.

Authors:  Jamie L Huizinga; Elizabeth E Stanley; James K Sullivan; Shuang Song; David J Hunter; A David Paltiel; Tuhina Neogi; Robert R Edwards; Jeffrey N Katz; Elena Losina
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-05-10       Impact factor: 5.178

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.